Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Comment by Fantomatuson Aug 29, 2009 4:59pm
267 Views
Post# 16261491

RE: 10 suspicions vs 1 evidence

RE: 10 suspicions vs 1 evidence1- Concerning the lack of efforts to promote Cur to financial markets, I think you're right to
a certain extent. But Cur has a poor sex appeal ( if I may say so) for these guys: poor revenues,
weak sales and huge expenses (R&D),and it is risky. Its book value at 57 cents.
But with the last good news we had, their perception will change and their mind too.Gradually,
Cur will become a real value, and not only a "valeur d'espoir" with great potential. They will
become hungry of Cur.

If you permit me , I'll come back for the others points. I'm tired of being in front of my pc...

Salutations !

Fantomatus

Bullboard Posts